Calvin Kwon, Pharm D
About Calvin Kwon, Pharm D
Calvin Kwon, PharmD, is a Clinical Trial Lead in Melanoma Medical Evidence Generation at Bristol Myers Squibb, with extensive experience in oncology and clinical pharmacy.
Title and Current Role
Calvin Kwon currently holds the position of Clinical Trial Lead for Melanoma and Medical Evidence Generation at Bristol Myers Squibb. In this role, he is responsible for overseeing clinical trials related to melanoma and contributing to the generation of medical evidence to support therapeutic strategies and patient outcomes.
Professional Experience in Oncology
Calvin Kwon has extensive experience in the field of oncology, having served in multiple roles at Bristol Myers Squibb. His journey at the company includes positions such as Field Medical Scientist (Medical Science Liaison) in Immuno-Oncology, Oncology Field Medical and Communication Specialist, Field Medical Operations Project Manager for Oncology, and currently as Clinical Trial Lead for Melanoma. His work spans medical liaison, communication, operations management, and clinical trial leadership.
Pharmacy Background and Career Progression
Before his tenure at Bristol Myers Squibb, Calvin Kwon built a solid foundation in pharmacy. He started as a Pharmacy Technician at Saint Peter’s Healthcare System, eventually becoming a Pharmacist and serving in that capacity for six years. His pharmacy expertise also includes working as a Pharmacist at Regional Cancer Care Associates. This progression demonstrates his deep clinical knowledge and experience in pharmacy practice.
Education in Pharmacy
Calvin Kwon earned his Doctor of Pharmacy (PharmD) degree from Rutgers, The State University of New Jersey-New Brunswick. His comprehensive education in pharmacy has laid the groundwork for his career in clinical pharmacy, oncology, and medical evidence generation.
Early Career Experience
Calvin Kwon's early career includes a notable internship at Novartis, where he worked as an Oncology Data Management Intern. This role involved managing oncology data and contributed to his foundation in oncology research and data management. Such early experiences have been crucial in his professional development in the field of oncology.